The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Amino-1-(3,4-dihydroxy-5-methyl-tetrahydro-furan-2-yl)-5-vinyl-1H-pyrimidin-2-one ID: ALA3350548
Cas Number: 216450-09-8
PubChem CID: 54437788
Max Phase: Preclinical
Molecular Formula: C11H15N3O4
Molecular Weight: 253.26
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c(=O)nc1N
Standard InChI: InChI=1S/C11H15N3O4/c1-3-6-4-14(11(17)13-9(6)12)10-8(16)7(15)5(2)18-10/h3-5,7-8,10,15-16H,1H2,2H3,(H2,12,13,17)/t5-,7-,8-,10-/m1/s1
Standard InChI Key: WLXYZJRKLHXRBP-VPCXQMTMSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
6.6369 -2.1072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8523 -2.3621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5931 -1.0452 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8085 -1.3002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2500 -2.6592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0347 -2.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1849 -1.8772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2062 -1.5973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5974 -3.1467 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5175 -2.3621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7724 -3.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6478 -2.9563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1954 -0.7482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9908 -1.3423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1849 -1.0522 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4324 -2.7013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7328 -2.1072 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2875 -3.8142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 6
3 4 1 0
4 1 1 0
5 1 1 0
6 5 2 0
7 2 1 0
8 6 1 0
9 2 1 0
10 7 1 0
11 9 1 0
12 6 1 0
13 4 2 0
14 8 1 0
7 15 1 1
16 12 2 0
10 17 1 1
11 18 1 6
3 8 2 0
11 10 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 253.26Molecular Weight (Monoisotopic): 253.1063AlogP: -0.89#Rotatable Bonds: 2Polar Surface Area: 110.60Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.59CX Basic pKa: ┄CX LogP: -1.21CX LogD: -1.21Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.63Np Likeness Score: 1.42
References 1. Hattori K, Kohchi Y, Oikawa N, Suda H, Ura M, Ishikawa T, Miwa M, Endoh M, Eda H, Tanimura H, Kawashima A, Horii I, Ishitsuka H, Shimma N.. (2003) Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine., 13 (5): [PMID:12617910 ] [10.1016/s0960-894x(02)01082-x ]